Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis
AbstractBackground The exhaustive information about non-communicable diseases associated with COVID-19 and severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) are getting easier to find in the literature. However, there is a lack of knowledge regarding tuberculosis (TB) and chronic obstruc...
Main Authors: | Muhammad Muneeb Hassan, Muhammad Ameeq, Farrukh Jamal, Muhammad H. Tahir, John T. Mendy |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2022.2160491 |
Similar Items
-
Risk factors identification of COVID‐19 patients with chronic obstructive pulmonary disease: A retrospective study in Punjab‐Pakistan
by: Muhammad Muneeb Hassan, et al.
Published: (2023-08-01) -
Therapy correction of concerned chronic heart failure and chronic obstructive pulmonary disease in a patient with first identified pulmonary tuberculosis. Case report
by: Natalia V. Bagisheva, et al.
Published: (2022-05-01) -
Cardiovascular pathology in patients with newly diagnosed tuberculosis and chronic obstructive pulmonary disease
by: N. V. Bagisheva, et al.
Published: (2021-10-01) -
Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study
by: Iseul Yu, et al.
Published: (2022-07-01) -
Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease
by: Alex Kayongo, et al.
Published: (2023-06-01)